Cancer Letters
Volume 253, Issue 1 , Pages 108-114 , 8 August 2007

Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells

  • Song Zhang

      Affiliations

    • Department of Otolaryngology, Union Hospital of Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430022, China
    • The first two authors contributed equally to this work.
    • ,
  • Ju-Hong Yang

      Affiliations

    • Department of Laboratory, Union Hospital of Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430022, China
    • Corresponding Author InformationCorresponding author. Present address: 1277 Jiefang Dadao Avenue, Union Hospital, Wuhan, Hubei 430022, China. Tel.: +86 27 62743701; fax: +86 27 85776343.
    • The first two authors contributed equally to this work.
    • ,
  • Chang-Kai Guo

      Affiliations

    • Department of Otolaryngology, Union Hospital of Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430022, China
    • ,
  • Peng-cheng Cai

      Affiliations

    • Department of Laboratory, Union Hospital of Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430022, China

Received 11 December 2006 ,Accepted 15 January 2007.

References 

  1. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNAi in Caenorhabditis elegans. Nature. 1998;391:806–811
  2. Cerutti H. RNA interference: traveling in the cell and gaining functions?. Trends Genet. 2003;19:39–46
  3. Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature. 2004;431:371–378
  4. Izquierdo M. Short interfering RNAs as a tool for cancer gene therapy. Cancer Gene. Ther. 2005;12:217–227
  5. Caplen NJ. Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference. Gene Therapy. 2004;11:1241–1248
  6. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494–498
  7. Hannon GJ. RNA interference. Nature. 2002;418:244–251
  8. Warburg O, Posener K, Negelein E, et al. Uber den Stoffwechsel der Carcinomzelle. Biochem. Z. 1924;152:309–344
  9. Boros LG, Puigjaner J, Cascante M, Lee WN, Brandes JL, Bassilian S, et al. Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res. 1997;57:4242–4248
  10. Langbein S, Zerilli M, Zur Hausen A, Staiger W, Rensch-Boschert K, Lukan N, et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. Br. J. Cancer. 2006;94:578–585
  11. Ramanathan A, Wang C, Schreiber SL. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc. Natl. Acad. Sci. USA. 2005;102:5992–5997
  12. Coy JF, Dressler D, Wilde J, Schubert P. Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Clin. Lab. 2005;51:257–273
  13. Smeets EH, Muller H, de Wael J. A NADH-dependent transketolase assay in erythrocyte hemolysates. Clin. Chim. Acta. 1971;33:379–386
  14. Rais B, Comin B, Puigjaner J, Brandes JL, Creppy E, Saboureau D, et al. Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich’s tumor cells through inhibition of the pentose cycle. FEBS Lett. 1999;456:113–118
  15. Glinsky GV, Krones-Herzig A, Glinskii AB. Malignancy-associated regions of transcriptional activation: gene expression profiling identifies common chromosomal regions of a recurrent transcriptional activation in human prostate, breast, ovarian, and colon cancers. Neoplasia. 2003;5:218–228
  16. Comin-Anduix B, Boren J, Martinez S, Moro C, Centelles JJ, Trebukhina R, et al. The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study. Eur. J. Biochem. 2001;268:4177–4182
  17. Weng G, Bhalla US, Iyengar R. Complexity in biological signaling systems. Science. 1999;284:92–96
  18. Garber K. Energy deregulation: licensing tumors to grow. Science. 2006;312:1158–1159
  19. Kim JW, Dang CV. Cancer’s molecular sweet tooth and the Warburg effect. Cancer Res. 2006;66:8927–8930
  20. Pelicano H, Martin DS, Xu RH, Huang P. Glycolysis inhibition for anticancer treatment. Oncogene. 2006;25:4633–4646
  21. Xu RH, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN, et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 2005;65:613–621

PII: S0304-3835(07)00017-1

doi: 10.1016/j.canlet.2007.01.010

Cancer Letters
Volume 253, Issue 1 , Pages 108-114 , 8 August 2007

Article Tools

* Image Usage & Resolution